Latest News

Trump tries to convince voters he’s lowered drug prices, based only on a modest tweak to Medicare

WASHINGTON — President Trump used a glitzy Rose Garden address, flanked by pharmaceutical company CEOs and patient advocates, to boast of his administration’s successes lowering drug prices and to detract from his political rivals’ efforts on the same issue.

But the news he was touting was modest at best: Drug makers agreed to participate in a minor, voluntary Medicare program that will likely only provide a limited discount on insulin for a small subset of the 60 million seniors with Medicare coverage.

Read the rest…

Source link

Related posts

The Betelgeuse Star Is Acting Weird, Per Scientists


Digital pathology startup Proscia lands $8.3M


Handheld Photonic Device Measures Arterial Stiffness


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World